Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hMG in ART Cycle for Infertility
NCT07216742Phase 3Recruiting
- Sponsor
- Granata Bio
- Start
- Nov 2025
- Primary completion
- Nov 2028
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of human menopausal gonadotrophin in infertility, sponsored by Granata Bio. Started Nov 2025; status: recruiting.
02
Drugs
human menopausal gonadotrophin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT07216742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07216742.